What is the recommended dosing of Effexor (venlafaxine) in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Venlafaxine (Effexor) Dosing in Adults

For adults with depression, venlafaxine should be started at 75 mg/day in 2-3 divided doses, then titrated up to 150-225 mg/day with a maximum dose of 375 mg/day. 1

Initial Dosing and Titration

  • Starting dose: 75 mg/day, administered in two or three divided doses, taken with food 1
  • Titration: Increase by 75 mg/day at intervals of no less than 4 days 1
  • Target dose: 150-225 mg/day for most patients 1
  • Maximum dose: 375 mg/day, generally in three divided doses 1

Dosing Considerations by Formulation

Immediate-Release (IR)

  • Administer in 2-3 divided doses daily with food
  • More frequent dosing may help reduce nausea and other side effects

Extended-Release (XR)

  • Once-daily dosing (usually in the morning)
  • May have fewer side effects than immediate-release formulation
  • Equivalent efficacy to immediate-release when dosed appropriately

Dose Adjustments for Special Populations

Hepatic Impairment

  • Mild to moderate impairment: Reduce total daily dose by 50% 1
  • Severe impairment: Consider further dose reduction and individualization
  • Monitor closely as there is significant variability in clearance among patients with hepatic impairment 1

Renal Impairment

  • Mild to moderate impairment (GFR 10-70 mL/min): Reduce total daily dose by 25% 1
  • Hemodialysis patients: Reduce total daily dose by 50% 1
  • Individualize dosing due to variability in clearance 1

Elderly Patients

  • No specific dose adjustment required based on age alone 1
  • However, exercise caution when increasing the dose
  • Consider starting at lower doses and titrating more slowly

Dosing for Specific Conditions

Major Depression

  • Effective dose range: 75-375 mg/day 1
  • Outpatients typically respond to 75-225 mg/day 1
  • More severely depressed inpatients may require up to 350-375 mg/day 1

Neuropathic Pain

  • Starting dose: 37.5 mg once or twice daily 2
  • Titration: Increase by 75 mg each week 2
  • Target dose: 150-225 mg/day 2
  • Duration of adequate trial: 4-6 weeks 2

Monitoring and Follow-up

  • Assess efficacy after 4-6 weeks of treatment at an adequate dose
  • Monitor blood pressure regularly, as venlafaxine can cause increases in blood pressure, particularly at higher doses 2
  • Watch for cardiac conduction abnormalities, especially in patients with pre-existing cardiac disease 2
  • Taper gradually when discontinuing to avoid withdrawal syndrome 2

Common Pitfalls and Considerations

  • Underdosing: Many patients are maintained on subtherapeutic doses (75 mg/day) when they might benefit from higher doses 3
  • Blood pressure effects: Monitor blood pressure regularly, especially when using doses above 225 mg/day
  • Withdrawal syndrome: Always taper gradually when discontinuing venlafaxine to prevent withdrawal symptoms 2
  • Drug interactions: Use caution when combining with MAOIs, other serotonergic drugs, or CYP2D6 inhibitors
  • Pregnancy: Use with caution during pregnancy, especially in the third trimester, as neonates may develop complications requiring prolonged hospitalization 1

Remember that while higher doses (up to 600 mg/day) have been used in clinical practice for treatment-resistant depression 4, the FDA-approved maximum dose is 375 mg/day, and doses above this level should be used with extreme caution and close monitoring.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.